DHA-dFdC

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDHA-dFdC
Drug Alias NameDHA-gemcitabine - CBM BioPharmaGemcitabine docosahexaenoic acid conjugate - CBM BioPharmaGemcitabine DHA conjugate - CBM BioPharmaDHA dFdCDHA-dFdC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A